Cargando…
A novel noble metal stent coating reduces in vitro platelet activation and acute in vivo thrombosis formation: a blinded study
Inherent to any stenting procedure is the prescription of dual antiplatelet therapy (DAPT) to reduce the platelet response. Clinical guidelines recommend 6–12 months of DAPT, depending on stent type, clinical picture and patient factors. Our hypothesis is that a nanostructured noble metal coating ha...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567768/ https://www.ncbi.nlm.nih.gov/pubmed/37821529 http://dx.doi.org/10.1038/s41598-023-44364-4 |
_version_ | 1785119205579816960 |
---|---|
author | Sandell, Mikael Ericsson, Anna Al-Saadi, Jonathan Södervall, Billy Södergren, Erika Grass, Stefan Sanchez, Javier Holmin, Staffan |
author_facet | Sandell, Mikael Ericsson, Anna Al-Saadi, Jonathan Södervall, Billy Södergren, Erika Grass, Stefan Sanchez, Javier Holmin, Staffan |
author_sort | Sandell, Mikael |
collection | PubMed |
description | Inherent to any stenting procedure is the prescription of dual antiplatelet therapy (DAPT) to reduce the platelet response. Clinical guidelines recommend 6–12 months of DAPT, depending on stent type, clinical picture and patient factors. Our hypothesis is that a nanostructured noble metal coating has the potential to reduce protein deposition and platelet activation. These effects would reduce subsequent thrombo-inflammatory reactions, potentially mitigating the need for an extensive DAPT in the acute phase. Here, a noble metal nanostructure coating on stents is investigated. Twelve pigs underwent endovascular implantation of coated and non-coated stents for paired comparisons in a blinded study design. The non-coated control stent was placed at the contralateral corresponding artery. Volumetric analysis of angiographic data, performed by a treatment blinded assessor, demonstrated a significant thrombus reduction for one of the coatings compared to control. This effect was already seen one hour after implantation. This finding was supported by in vitro data showing a significant reduction of coagulation activation in the coated group. This novel coating shows promise as an implant material addition and could potentially decrease the need for DAPT in the early phases of stent implementation. |
format | Online Article Text |
id | pubmed-10567768 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-105677682023-10-13 A novel noble metal stent coating reduces in vitro platelet activation and acute in vivo thrombosis formation: a blinded study Sandell, Mikael Ericsson, Anna Al-Saadi, Jonathan Södervall, Billy Södergren, Erika Grass, Stefan Sanchez, Javier Holmin, Staffan Sci Rep Article Inherent to any stenting procedure is the prescription of dual antiplatelet therapy (DAPT) to reduce the platelet response. Clinical guidelines recommend 6–12 months of DAPT, depending on stent type, clinical picture and patient factors. Our hypothesis is that a nanostructured noble metal coating has the potential to reduce protein deposition and platelet activation. These effects would reduce subsequent thrombo-inflammatory reactions, potentially mitigating the need for an extensive DAPT in the acute phase. Here, a noble metal nanostructure coating on stents is investigated. Twelve pigs underwent endovascular implantation of coated and non-coated stents for paired comparisons in a blinded study design. The non-coated control stent was placed at the contralateral corresponding artery. Volumetric analysis of angiographic data, performed by a treatment blinded assessor, demonstrated a significant thrombus reduction for one of the coatings compared to control. This effect was already seen one hour after implantation. This finding was supported by in vitro data showing a significant reduction of coagulation activation in the coated group. This novel coating shows promise as an implant material addition and could potentially decrease the need for DAPT in the early phases of stent implementation. Nature Publishing Group UK 2023-10-11 /pmc/articles/PMC10567768/ /pubmed/37821529 http://dx.doi.org/10.1038/s41598-023-44364-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Sandell, Mikael Ericsson, Anna Al-Saadi, Jonathan Södervall, Billy Södergren, Erika Grass, Stefan Sanchez, Javier Holmin, Staffan A novel noble metal stent coating reduces in vitro platelet activation and acute in vivo thrombosis formation: a blinded study |
title | A novel noble metal stent coating reduces in vitro platelet activation and acute in vivo thrombosis formation: a blinded study |
title_full | A novel noble metal stent coating reduces in vitro platelet activation and acute in vivo thrombosis formation: a blinded study |
title_fullStr | A novel noble metal stent coating reduces in vitro platelet activation and acute in vivo thrombosis formation: a blinded study |
title_full_unstemmed | A novel noble metal stent coating reduces in vitro platelet activation and acute in vivo thrombosis formation: a blinded study |
title_short | A novel noble metal stent coating reduces in vitro platelet activation and acute in vivo thrombosis formation: a blinded study |
title_sort | novel noble metal stent coating reduces in vitro platelet activation and acute in vivo thrombosis formation: a blinded study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567768/ https://www.ncbi.nlm.nih.gov/pubmed/37821529 http://dx.doi.org/10.1038/s41598-023-44364-4 |
work_keys_str_mv | AT sandellmikael anovelnoblemetalstentcoatingreducesinvitroplateletactivationandacuteinvivothrombosisformationablindedstudy AT ericssonanna anovelnoblemetalstentcoatingreducesinvitroplateletactivationandacuteinvivothrombosisformationablindedstudy AT alsaadijonathan anovelnoblemetalstentcoatingreducesinvitroplateletactivationandacuteinvivothrombosisformationablindedstudy AT sodervallbilly anovelnoblemetalstentcoatingreducesinvitroplateletactivationandacuteinvivothrombosisformationablindedstudy AT sodergrenerika anovelnoblemetalstentcoatingreducesinvitroplateletactivationandacuteinvivothrombosisformationablindedstudy AT grassstefan anovelnoblemetalstentcoatingreducesinvitroplateletactivationandacuteinvivothrombosisformationablindedstudy AT sanchezjavier anovelnoblemetalstentcoatingreducesinvitroplateletactivationandacuteinvivothrombosisformationablindedstudy AT holminstaffan anovelnoblemetalstentcoatingreducesinvitroplateletactivationandacuteinvivothrombosisformationablindedstudy AT sandellmikael novelnoblemetalstentcoatingreducesinvitroplateletactivationandacuteinvivothrombosisformationablindedstudy AT ericssonanna novelnoblemetalstentcoatingreducesinvitroplateletactivationandacuteinvivothrombosisformationablindedstudy AT alsaadijonathan novelnoblemetalstentcoatingreducesinvitroplateletactivationandacuteinvivothrombosisformationablindedstudy AT sodervallbilly novelnoblemetalstentcoatingreducesinvitroplateletactivationandacuteinvivothrombosisformationablindedstudy AT sodergrenerika novelnoblemetalstentcoatingreducesinvitroplateletactivationandacuteinvivothrombosisformationablindedstudy AT grassstefan novelnoblemetalstentcoatingreducesinvitroplateletactivationandacuteinvivothrombosisformationablindedstudy AT sanchezjavier novelnoblemetalstentcoatingreducesinvitroplateletactivationandacuteinvivothrombosisformationablindedstudy AT holminstaffan novelnoblemetalstentcoatingreducesinvitroplateletactivationandacuteinvivothrombosisformationablindedstudy |